Nasdaq:VREX
Varex Imaging Corp
A specialized image sensor manufacturer providing critical components for industrial, security, and medical imaging systems with a strong cash position but recent net losses.
Key Metrics
Investment Thesis
Bull Case
Varex possesses a unique niche in high-end image sensors with proprietary technology that is difficult for competitors to replicate quickly. The substantial cash reserve of $145M provides a buffer to weather the current loss period while investing heavily in R&D totaling $91.1M to secure future growth. Revenue recovery trends suggest potential operational stabilization as the company optimizes its cost structure and inventory levels.
Bear Case
Consecutive years of negative net income, dropping from $48.7M profit in 2023 to a $69.9M loss in 2025, indicate deepening fundamental problems. The massive increase in inventory by nearly $40M signals potential demand weakness or obsolete stock that will require future write-downs. Operating expenses remain high at $318.3M while profitability has collapsed, suggesting significant structural inefficiencies that may not be easily resolved.
About Varex Imaging Corp
Varex Imaging Corp designs and manufactures high-performance image sensors for diverse applications including industrial imaging, security surveillance, and medical devices. The company serves global markets with its proprietary CCD and CMOS sensor technologies, positioning itself as a specialized supplier in the broader semiconductor industry. Recent financial data highlights significant investment in research and development alongside challenges in maintaining profitability amidst revenue fluctuations.
Analysis
Management Discussion
The company reported a net loss of $69.9M in 2025 following a smaller loss in 2024, while revenue recovered slightly to $844.6M from the previous year's $811.0M after peaking at $893.4M in 2023. Cash flow from operations improved to $41.7M despite the net loss, supported by non-cash adjustments of $56.2M and manageable capital expenditures of $22.9M against a strong cash balance.
Industry Overview
The global image sensor market is experiencing rapid growth driven by demands from smart cities, autonomous vehicles, and advanced medical diagnostics. Competition is intensifying from both legacy CCD manufacturers transitioning to CMOS and new entrants leveraging AI-driven design tools. Companies with specialized expertise in niche applications like industrial inspection tend to command premium pricing despite overall industry margin compression.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $893.4M | $811.0M | $844.6M |
| Cost of Revenue | $603.1M | $554.1M | $554.1M |
| Gross Profit | $290.3M | $256.9M | $290.5M |
| Operating Expenses | $213.2M | $224.8M | $318.3M |
| Operating Income | $77.1M | $32.1M | $-27.8M |
| R&D | $84.8M | $87.0M | $91.1M |
| G&A | $128.4M | $137.8M | $133.3M |
| Stock-Based Comp | $13.5M | $15.3M | $15.0M |
| Depreciation | $19.5M | $21.2M | $23.2M |
| Amortization | $13.7M | $9.9M | $4.0M |
| Other OpEx | $0 | $0 | $93.9M |
| Non-Operating Income | $-45.8M | $-27.1M | $-31.4M |
| Interest Expense | $29.3M | — | — |
| Interest Income | $3.7M | $7.3M | $8.5M |
| Pre-Tax Income | $31.3M | $5.0M | $-59.2M |
| Income Tax | $-17.4M | $52.2M | $10.7M |
| Continuing Ops | $48.7M | $-47.2M | $-69.9M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $48.7M | $-47.2M | $-69.9M |
| Minority Interest | $500.0K | $500.0K | $400.0K |
| Net to Common | $48.2M | $-47.7M | $-70.3M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $658.3M | $649.9M | $641.8M |
| Cash & Equivalents | $152.6M | $168.7M | $145.0M |
| Marketable Securities | — | $31.8M | $10.1M |
| Accounts Receivable | $163.6M | $157.7M | $156.6M |
| Inventory | $277.5M | $264.8M | $299.4M |
| Prepaid Expenses | $64.6M | $26.9M | $30.7M |
| Other Current Assets | $0 | $0 | $0 |
| Long-Term Assets | $591.3M | $567.1M | $465.6M |
| Intangibles | $22.4M | $16.1M | $14.0M |
| Goodwill | $288.5M | $291.0M | $198.4M |
| Operating Leases | $29.0M | $28.3M | $29.4M |
| Other LT Assets | $251.4M | $231.7M | $223.8M |
| Total Assets | $1.25B | $1.22B | $1.11B |
| Current Liabilities | $162.8M | $195.9M | $187.2M |
| Accounts Payable | $64.7M | $59.1M | $69.9M |
| Current Debt | $1.5M | $46.3M | $1.5M |
| Current Leases | $3.8M | $4.0M | $4.4M |
| Deferred Revenue | $10.2M | $7.9M | $13.0M |
| Taxes Payable | $13.3M | $8.1M | $5.3M |
| Other Current Liab | $-13.3M | $-8.1M | $-5.3M |
| Long-Term Liabilities | $505.8M | $471.9M | $433.6M |
| Long-Term Debt | $441.1M | $397.1M | $366.0M |
| LT Operating Leases | $23.1M | $23.0M | $24.0M |
| Other LT Liab | $37.0M | $47.8M | $41.3M |
| Total Liabilities | $668.6M | $667.8M | $620.8M |
| Shareholders' Equity | $581.0M | $549.2M | $486.6M |
| Paid-In Capital | $450.4M | $467.2M | $483.3M |
| Retained Earnings | $118.1M | $70.4M | $-5.9M |
| AOCI | $-1.2M | $-2.9M | $-5.2M |
| Total L&E | $1.25B | $1.22B | $1.11B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $48.7M | $-47.2M | $-69.9M |
| Non-Cash Adjustments | $110.4M | $125.7M | $56.2M |
| Working Capital Changes | $-50.7M | $-31.2M | $55.4M |
| Cash from Operations | $108.4M | $47.3M | $41.7M |
| Capital Expenditures | $20.7M | $26.9M | $22.9M |
| Cash from Investing | $-44.9M | $-27.5M | $10.3M |
| Cash from Financing | $-200.0K | $-3.3M | $-75.9M |
| FX Effect | $100.0K | $-100.0K | $600.0K |
| Net Change in Cash | $63.4M | $16.4M | $-23.3M |
| Beginning Cash | $90.6M | $154.0M | $170.4M |
| Ending Cash | $154.0M | $170.4M | $147.1M |
Frequently Asked Questions
How does Varex Imaging Corp make money?
Industrial Imaging Solutions serving manufacturing automation and inspection; Security and Surveillance Sensors targeting the growing global security market; Medical Imaging Devices including X-ray and ultrasound sensors; Specialized Sensor Applications for scientific research and aerospace sectors.
What are the main risks for VREX?
Sustained net losses of $69.9M in 2025 raising concerns about long-term profitability and operational efficiency. Significant inventory buildup of $39.9M change indicating potential overproduction or slowing demand absorption. High operating expenses of $318.3M relative to gross profit margins creating pressure on cash flow generation. Dependence on cyclical industrial and medical equipment markets which may face economic downturns affecting order volumes.
What is VREX's competitive advantage?
Proprietary image sensor architectures that offer superior low-light performance and high dynamic range compared to legacy CCD technologies. Established long-term relationships with major industrial and medical equipment manufacturers ensuring recurring revenue streams. Strong balance sheet with over $145M in cash and equivalents providing flexibility for R&D investments despite current losses.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.